Evidence map›Paper›PMID 30080416›Full record

ArticleJournal of proteome research2018

Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles.

Xiaofeng Wu, Li Li, Anton Iliuk, W Andy Tao

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Plasma-Derived Extracellular Vesicle Proteomics.Journal of proteome research · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Proteomic analysis and in vivo visualization of extracellular vesicles from mouse oviducts during pre-implantation embryo development.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xiaofeng Wu
Li LiTymora Analytical Operations , West Lafayette , Indiana 47906 , United States.
Anton IliukTymora Analytical Operations , West Lafayette , Indiana 47906 , United States.
W Andy TaoTymora Analytical Operations , West Lafayette , Indiana 47906 , United States.ORCID 0000-0002-5535-5517
Tymora Analytical Operations (United States) · USPurdue University West Lafayette · US

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteomeR44CA239845 · NCI · TYMORA ANALYTICAL OPERATIONS, LLC · PI ILIUK, ANTON · 2019 to 2021
$1.5M
A Proteomic Platform to identify and Validate Biomarkers in Metabolic Syndrome and Coronary Artery DiseaseR01GM111788 · NIGMS · PURDUE UNIVERSITY · PI TAO, W. ANDY · 2015 to 2017
$900k
Developing novel RPPA for the detection of metastatic prostate cancerR41CA210772 · NCI · TYMORA ANALYTICAL OPERATIONS, LLC · PI TAO, W. ANDY · 2016 to 2018
$227k
NCI NIH HHS P30 CA023168NCI NIH HHS R41 CA210772NCI NIH HHS R44 CA239845NIGMS NIH HHS R01 GM111788
6 · The paper itself

Abstract

Analysis of protein phosphorylation in extracellular vesicles (EVs) offers an unprecedented potential for understanding cancer signaling and early stage disease diagnosis. However, prior to the phosphoproteome analysis step, the isolation of EVs from biofluids remains a challenging issue to overcome due to the low yield and impurity from current isolation methods. Here, we carry out an extensive assessment of several EV isolation methods including a novel rapid isolation method EVTRAP for highly efficient capture of extracellular vesicles from human urine sample. We demonstrate that over 95% recovery yield can be consistently achieved by EVTRAP, a significant improvement over current standard techniques. We then applied EVTRAP to identify over 16 000 unique peptides representing 2000 unique EV proteins from 200 μL urine sample, including all known EV markers with substantially increased recovery levels over ultracentrifugation. Most importantly, close to 2000 unique phosphopeptides were identified from more than 860 unique phosphoproteins using 10 mL of urine. The data demonstrated that EVTRAP is a highly effective and potentially widely implementable clinical isolation method for analysis of EV protein phosphorylation.

Indexed as

BiomarkersChemistry Techniques, AnalyticalExtracellular VesiclesHumansHydrophobic and Hydrophilic InteractionsMagnetsMitochondrial ProteinsMuscle ProteinsPhosphopeptidesPhosphoproteinsProtein BindingProteomeTetraspanin 29UltracentrifugationBiomarkersCD9 protein, humanIMMT protein, humanMitochondrial ProteinsMuscle ProteinsPhosphopeptidesPhosphoproteinsProteomeTetraspanin 29EVsEVTRAPexosomesextracellular vesiclesphosphoproteomicsurine

Identifiers

PMID30080416
PMCPMC7236337
OpenAlexW2886022119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.